Industry News
Genomic Data Leads To New Treatment For Follicular Lymphoma
Oct 30, 2011
New discoveries about follicular lymphoma, a currently intractable form of cancer, highlight the power of functional genomics in cancer gene discovery. A report in the Oct 28th issue of Cell, a Cell Press publication, demonstrates how genetic insights can be translated directly into therapies... Read More
Low-Fat Diet With Fish Oil Supplements Slows Growth Rate Of Prostate Cancer Cells
Oct 28, 2011
Researchers at UCLA's Jonsson Comprehensive Cancer Center have discovered that the growth of prostate cancer cells slowed down in men that ate a low-fat diet together with fish oil supplements for four to six weeks before prostate removal compared to men who ate a Western diet high in fat. The study appeared Oct... Read More
Idiopathic Pulmonary Fibrosis Survival Predicted With Blood Proteins
Oct 28, 2011
According to investigators at the University of Pittsburgh School of Medicine and Centocor R&D, a group of blood proteins can foresee which patients with idiopathic pulmonary fibrosis (IPF) - a progressive lung disease - are more likely to die within two years or live at least five years... Read More
Wart Treatment Compound May Treat Leukemia Effectively
Oct 28, 2011
Researchers have developed a new potential leukemia therapy that specifically targets cancerous cells, without attacking healthy cells. At present the majority of chemotherapy treatments attack both cancer cells and healthy cells, causing considerable adverse effects, such as depression, anxiety, nausea, hair loss and fatigue... Read More
Metastatic Colorectal Cancer - Regorafenib (BAY 73-4506) Improves Overall Survival
Oct 28, 2011
According to an announcement made by Bayer HealthCare Pharmaceuticals, the Phase III trial of its investigational compound regorafenib (BAY 73-4506) to treat individuals with metastatic colorectal cancer (mCRC) whose disease progressed after approved standard treatments has reached its initial endpoint of statistically significant improvement in overall survival... Read More
Preclinical Testing Shows Improved Effectiveness Of New Oncolytic Virus
Oct 28, 2011
A new fourth-generation oncolytic virus designed to both kill cancer cells and inhibit blood-vessel growth has shown greater effectiveness than earlier versions when tested in animal models of human brain cancer. Researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J... Read More
Abbott's Genetic Test For Acute Myeloid Leukemia Prognosis Cleared By FDA
Oct 28, 2011
Abbott (NYSE: ABT) announced it has received 510(k) clearance from the U.S. Food and Drug Administration for a new in vitro diagnostic test to aid in determining the prognosis of patients with acute myeloid leukemia (AML), one of the most common types of leukemia in older adults... Read More
HPV For Boys Doesn't Solve Problem, Says Association Of American Physicians And Surgeons
Oct 28, 2011
The CDC has added still another vaccine to the recommended list: three doses of human papillomavirus (HPV) vaccine (Gardasil) for boys age 11-12. HPV causes genital warts, and four of about 100 strains have been linked to cancer, especially cervical cancer in women... Read More
Compound Found In Common Wart Treatment Shows Promise As Leukemia Therapy
Oct 28, 2011
A new potential leukemia therapy targets only cancer cells, while leaving healthy cells alone. Many current chemotherapy treatments affect cancer cells and healthy cells, causing significant side effects, such as fatigue, hair loss, nausea, anxiety and depression... Read More
Gene Responsible For Relapses In Young Leukemia Patients
Oct 28, 2011
One of the causes of resistance to cancer treatment in children is now beginning to be elucidated. Acute lymphoblastic leukemia patients with a particular form of the ATF5 gene are at higher risk of having a relapse when treated with E. coli asparaginase, a key chemotherapy drug for this type of leukemia. This is what a study by Dr... Read More
Previous Page Next Page